Trade Mark Journal No.2026/040 2 October 2026

WO0000001937511 (5)

Office of origin: United States of America

Date of International Registration:14 July 2026
Date of designation in the UK: 14 July 2026
Image for mark 1937511

The mark consists of the word "LUMVOA" in black with the words "VELIGROTUG-VVZE" in lower case letters in black below to the left. The letter "O" in "LUMVOA" is depicted as a spoked spiral with the left spokes in black and the right spokes in purple.

The color(s) black and purple is/are claimed as a feature of the mark.

The mark consists of the word "LUMVOA" in black with the words "VELIGROTUG-VVZE" in lower case letters in black below to the left. The letter "O" in "LUMVOA" is depicted as a spoked spiral with the left spokes in black and the right spokes in purple.

International priority date claimed: 13 July 2026 (United States of America) (99936822)
Class 5
Pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of immune system related diseases and disorders.

Viridian Therapeutics, Inc.

Representative: Valerie Brennan Plave Koch PLC, 3120 Fairview Park Drive, Suite 420, Falls Church VA 22042, UNITED STATES OF AMERICA